Literature DB >> 19480928

Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation.

Jenna L Cash1, Gemma E White, David R Greaves.   

Abstract

The acute inflammatory response occurs as a result of tissue injury or infection and is characterized by the coordinated recruitment of leukocytes in response to inflammatory mediators including chemokines. This process generally resolves within a matter of days, and normal tissue architecture is restored by a process of wound healing. Failure to resolve the injury can result in chronic inflammation. Much of our understanding of the specific mediators and cell types involved in acute inflammation has come from sterile peritonitis models. The injection of a wide range of irritants into the peritoneal cavity induces the hallmarks of inflammation, including pain, leukocyte infiltration, and synthesis of inflammatory mediators. Intraperitoneal injection of zymosan, a polysaccharide cell wall component derived from Saccharomyces cerevisiae, has been widely used as a self-resolving model of acute inflammation that peaks within a few hours and is cleared within 48 to 72 h. We have used the zymosan-induced peritonitis model extensively to quantify the recruitment of monocytes and neutrophils into the peritoneal cavity and to study the effects of existing and novel antiinflammatory drugs. We discuss some of the applications and advantages of the zymosan-induced peritonitis model and describe the method for analysis of leukocyte recruitment and inflammatory mediator production in response to zymosan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480928     DOI: 10.1016/S0076-6879(09)05417-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  56 in total

1.  Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.

Authors:  Xue-Qing Zhang; Orli Even-Or; Xiaoyang Xu; Mariska van Rosmalen; Lucas Lim; Suresh Gadde; Omid C Farokhzad; Edward A Fisher
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

2.  Development of therapeutic polymeric nanoparticles for the resolution of inflammation.

Authors:  Suresh Gadde; Orli Even-Or; Nazila Kamaly; Apoorva Hasija; Philippe G Gagnon; Krishna H Adusumilli; Andrea Erakovic; Anoop K Pal; Xue-Qing Zhang; Nagesh Kolishetti; Jinjun Shi; Edward A Fisher; Omid C Farokhzad
Journal:  Adv Healthc Mater       Date:  2014-03-24       Impact factor: 9.933

3.  No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse.

Authors:  Eirunn Knudsen; Harald Carlsen; Arne Bøyum; Haakon Breien Benestad; Per Ole Iversen
Journal:  Int J Hematol       Date:  2014-05-24       Impact factor: 2.490

4.  Defective apoptotic cell contractility provokes sterile inflammation, leading to liver damage and tumour suppression.

Authors:  Linda Julian; Gregory Naylor; Grant R Wickman; Nicola Rath; Giovanni Castino; David Stevenson; Sheila Bryson; June Munro; Lynn McGarry; Margaret Mullin; Alistair Rice; Armandodel Del Río Hernández; Michael F Olson
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

5.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

6.  Lipid homeostasis and inflammatory activation are disturbed in classically activated macrophages with peroxisomal β-oxidation deficiency.

Authors:  Ivana Geric; Yulia Y Tyurina; Olga Krysko; Dmitri V Krysko; Evelyn De Schryver; Valerian E Kagan; Paul P Van Veldhoven; Myriam Baes; Simon Verheijden
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

7.  Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.

Authors:  Lina Herrera Estrada; Huixia Wu; Kevin Ling; Guikai Zhang; Ronen Sumagin; Charles A Parkos; Rheinallt M Jones; Julie A Champion; Andrew S Neish
Journal:  ACS Nano       Date:  2017-09-05       Impact factor: 15.881

8.  Assessment of myeloperoxidase activity by the conversion of hydroethidine to 2-chloroethidium.

Authors:  Ghassan J Maghzal; Katie M Cergol; Sudhir R Shengule; Cacang Suarna; Darren Newington; Anthony J Kettle; Richard J Payne; Roland Stocker
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

9.  Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution.

Authors:  Andreas Körner; Enchen Zhou; Christoph Müller; Yassene Mohammed; Sandra Herceg; Franz Bracher; Patrick C N Rensen; Yanan Wang; Valbona Mirakaj; Martin Giera
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

10.  Alveolar Epithelial Cell-Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation.

Authors:  Jennifer M Speth; Emilie Bourdonnay; Loka Raghu Kumar Penke; Peter Mancuso; Bethany B Moore; Jason B Weinberg; Marc Peters-Golden
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.